Selected Publications

  • An mRNA Immunotherapy for Type 1 Diabetes. Diabetes 20 June 2025; 74 (Supplement_1): 2003–LB. https://doi.org/10.2337/db25-2003-LB

  • An mRNA immunotherapy for the prevention and reversal of type 1 diabetes. (2025). Diabetologia, 68 (Suppl 1), 1–754 https://doi.org/10.1007/s00125-025-06497-1

  • Islet amyloid disrupts MHC Class II antigen presentation and protects NOD mice from autoimmune diabetes. Accepted in Diabetologia, September 16, 2025. PREPRINT (Version 1) available at bioRxiv. [https://doi.org/10.1101/2024.09.10.612362]

  • An mRNA vaccine induces immune tolerance and protects against disease in NOD mice 60th EASD Annual Meeting of the European Association for the Study of Diabetes. (2024) Diabetologia 67 (Suppl 1), 1–593  https://doi.org/10.1007/s00125-024-06226-0

  • Tolerogenic mRNA vaccine protects against murine type 1 diabetes, The Journal of Immunology, Volume 212, Issue 1_Supplement, May 2024, Page 1446_4845, https://doi.org/10.4049/jimmunol.212.supp.1446.4845

  • Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer. Cancers (Basel). 2022 Dec 13;14(24) https://doi.org/10.3390/cancers14246137

  • Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery, Small. 17 (2021). https://doi.org/10.1002/smll.202103025.

  • The current landscape of nucleic acid therapeutics, Nature Nanotechnology. 16 (2021) 630–643. https://doi.org/10.1038/s41565-021-00898-0.

  • Scalable Production of Lipid Nanoparticles Containing Amphotericin B, Langmuir. 37 (2021) 7312–7319. https://doi.org/10.1021/acs.langmuir.1c00530.

  • Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles, Nanoscale. 12 (2020) 23959–23966. https://doi.org/10.1039/d0nr06816k.

  • Lipid nanoparticle technology for therapeutic gene regulation in the liver, Advanced Drug Delivery Reviews. 159 (2020) 344–363. https://doi.org/10.1016/j.addr.2020.06.026.

  • Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads, Nanoscale. 11 (2019) 9023–9031. https://doi.org/10.1039/c9nr02004g.

  • Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids, Journal of Controlled Release. 286 (2018) 46–54. https://doi.org/10.1016/j.jconrel.2018.07.026.

  • On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA, ACS Nano. 12 (2018) 4787–4795. https://doi.org/10.1021/acsnano.8b01516.